Leucid Bio
Roisin Beehag has over 20 years of work experience, starting from 1998 to present. Roisin has held various roles in different companies, with their most recent position being a Senior Clinical Project Manager at Leucid Bio. Prior to this, they worked as a consultant at RB Clinical and spent more than six years at Cancer Research UK & UCL Cancer Trials Centre in various positions, including QA Manager and Regulatory Manager. Roisin also worked at UCL - Joint Research Office as a Regulatory Manager for the Advanced Therapies team. In addition, they have experience in pharmaceutical development, having worked as a Technical Development Analyst at Martindale Pharmaceuticals and as a Process Chemist at Evotec OAI. At Onyvax Limited, they played a significant role as a Project Manager for a Phase IIB multinational clinical trial.
Roisin Beehag received a National Certificate in Applied Biology from Munster Technological University in 1996. In 1997, they received a National Diploma in Analytical Sciences and Quality Management from the Institute of Technology in Carlow, and a B.Sc. (Hons) in Environmental and Industrial Chemistry from the University of Essex, Colchester. Roisin also obtained a Diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine, and attended the University of Bristol, although it is not specified if they obtained any degrees or field of study.
Leucid Bio
1 followers
Leucid Bio is a pioneering biotech company developing cell therapies for refractory cancers, especially solid tumors. Leucid was founded to translate 20 years of King's College London (King's) research in the CAR-T field and is led by a highly experienced management team with both scientific and commercial expertise. As part ofLeucid's ongoing relationship with King's, it benefits from exclusive access to and resources from the deep scientific, clinical, and manufacturing expertise of Dr. Maher and his academic team of immuno-oncology experts.